| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0004 |